Atlas Trials

International Multicenter Study of the Immunogenicity of Medicinal Product GamEvac-Combi

Clinical trial NCT03072030 · COMPLETED

Trial details

NCT number
NCT03072030
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Ebola Virus DiseasePrevention
Start date
2017-08-03
Primary completion
2019-12-31
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.